Ritholtz Wealth Management lifted its holdings in Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 9.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 206,455 shares of the company’s stock after buying an additional 17,024 shares during the period. Ritholtz Wealth Management owned about 0.26% of Pediatrix Medical Group worth $5,312,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Global Retirement Partners LLC acquired a new position in Pediatrix Medical Group during the second quarter valued at $33,000. Nykredit A S acquired a new stake in Pediatrix Medical Group during the 2nd quarter worth about $35,000. Parallel Advisors LLC acquired a new stake in Pediatrix Medical Group during the 3rd quarter worth about $49,000. Signaturefd LLC boosted its position in Pediatrix Medical Group by 301.8% during the 3rd quarter. Signaturefd LLC now owns 2,013 shares of the company’s stock worth $52,000 after acquiring an additional 1,512 shares during the period. Finally, Integrated Wealth Concepts LLC purchased a new position in Pediatrix Medical Group during the 2nd quarter valued at about $53,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.
Pediatrix Medical Group Stock Down 0.2%
Shares of Pediatrix Medical Group stock opened at $31.39 on Friday. The firm has a market cap of $2.45 billion, a price-to-earnings ratio of 17.06 and a beta of 0.62. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.28 and a quick ratio of 1.28. Pediatrix Medical Group, Inc. has a 52-week low of $17.23 and a 52-week high of $33.74. The stock has a 50-day simple moving average of $27.79 and a 200-day simple moving average of $24.29.
Pediatrix Medical Group (NYSE:MD – Get Free Report) last released its quarterly earnings data on Thursday, October 29th. The company reported $0.72 EPS for the quarter, topping analysts’ consensus estimates of $0.65 by $0.07. The firm had revenue of $501.37 million for the quarter, compared to the consensus estimate of $498.18 million. Pediatrix Medical Group had a return on equity of 20.12% and a net margin of 7.66%. The firm’s revenue was up 1.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.67 earnings per share. On average, equities research analysts expect that Pediatrix Medical Group, Inc. will post 2.21 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of brokerages have recently weighed in on MD. Weiss Ratings upgraded Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, September 9th. Mizuho lowered shares of Pediatrix Medical Group from a “neutral” rating to an “underperform” rating and set a $28.00 price target for the company. in a research report on Wednesday. UBS Group raised their price target on shares of Pediatrix Medical Group from $25.00 to $28.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. Deutsche Bank reaffirmed a “hold” rating and set a $25.00 price objective on shares of Pediatrix Medical Group in a research report on Wednesday, August 5th. Finally, Truist Financial upped their price objective on shares of Pediatrix Medical Group from $28.00 to $31.00 and gave the company a “hold” rating in a research note on Friday, October 30th. One research analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $28.00.
View Our Latest Stock Report on MD
Pediatrix Medical Group Company Profile
Pediatrix Medical Group provides physician services to hospitals and other healthcare facilities across the United States. Its clinicians care for women, newborns and children, working with healthcare partners to support patients in hospital and other clinical settings. The company’s services include neonatal care, maternal-fetal medicine and pediatric subspecialties. Its physicians and advanced practice providers deliver care such as treatment for high-risk pregnancies and specialized medical services for newborns and children.
See Also
- Five stocks we like better than Pediatrix Medical Group
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
